RT
Rgenta Therapeutics, Inc.
SEC filingOther Technology · Woburn, MA
Amount raised$41.9Msold at filing
Total offering$130.1M$88.3M still open
Investors in the raise9count reported to the SEC
FiledNov 3, 2026first sale Oct 19, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Hualin Simon XiExecutive Officer, Director
Yichao FanDirector
Debasish RoychowdhuryDirector
Julia KaufmanDirector
Sean ZhangDirector, Promoter
Cillian KingDirector, Promoter
James KasuboskiDirector
Travis WagerExecutive Officer
Weng ZhipingDirector
Jeff GuckertExecutive Officer
Executive officers, directors and promoters as listed on the Form D.